Skip to main content

Press releasePublished on 18 November 2026

Opportunities for cooperation with the EU in the supply of medicines

Bern, 18.11.2026 — Ensuring access to medicinal products for the public is increasingly an international challenge. At its meeting on 18 November, the Federal Council therefore approved a report on opportunities for cooperation with the EU to secure the supply of medicinal products in response to Postulate Golay (24.3216). In its analysis, the Federal Council primarily focuses on the health agreement, which was negotiated as part of the Switzerland-EU package (Bilaterals III). This lays the foundation for cooperation with the EU and better protection of the Swiss public in the event of a crisis.

The security of supply of medicinal products for human use and other important medical goods has deteriorated in Switzerland in recent years, with shortages becoming more common. The causes are many and complex. Security of supply is increasingly an international challenge that cannot be tackled exclusively at a national level. This becomes particularly clear in emergencies and crises, such as the COVID-19 pandemic.

Due to its geographical proximity, the existing bilateral relations and the close economic integration, the EU is also an important partner for Switzerland in the secure supply of medicinal products. Through numerous strategies, legal frameworks and initiatives, the EU is putting in place measures to improve security of supply. Against this backdrop, the Federal Council shares the basic assumption of Postulate 24.3216 – that closer cooperation between Switzerland and the EU on security of supply is worth reviewing. The report approved on 18 November constitutes this review.

Switzerland already makes use of existing opportunities for cooperation with the EU when initiatives are also open to third countries and no specific legal basis is required. However, as a non-EU member state, Switzerland has no or only very limited access to the EU’s other key mechanisms and initiatives in the field of security of supply.

A focus on the health agreement

Accordingly, the focus of the Federal Council’s analysis is primarily on the health agreement negotiated as part of the Switzerland-EU package (Bilaterals III). The health agreement represents an important step towards enhanced and legally regulated cooperation in the area of health security. The agreement gives Switzerland comprehensive access to the EU’s health security mechanisms and to the European Centre for Disease Prevention and Control (ECDC). This will improve the early warning and response capabilities of the Swiss authorities in the event of epidemics the protection the Swiss population.

Although security of supply and medicinal products are not part of the health agreement, the formalised cooperation can have a positive impact on security of supply in crisis situations. This is particularly true of the option, provided for in the health agreement, of voluntary participation in the joint procurement of medical goods, such as vaccines or protective equipment.

In addition, Switzerland is pursuing a diversified approach in order to make systematic use of opportunities to secure the supply of medicinal products. This includes maintaining and expanding networks at bilateral and multilateral level. Switzerland also advocates favourable conditions for foreign trade through free trade agreements and within multilateral bodies.

Further information